- Home
- NVGS vs YDES Comparison
NVGS vs YDES Comparison
Compare NVGS & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVGS
- YDES
- Stock Information
- Founded
- NVGS 1997
- YDES 2013
- Country
- NVGS United Kingdom
- YDES Taiwan
- Employees
- NVGS N/A
- YDES N/A
- Industry
- NVGS Marine Transportation
- YDES
- Sector
- NVGS Consumer Discretionary
- YDES
- Exchange
- NVGS Nasdaq
- YDES Nasdaq
- Market Cap
- NVGS 1.1B
- YDES 1.1B
- IPO Year
- NVGS N/A
- YDES N/A
- Fundamental
- Price
- NVGS $17.81
- YDES $9.17
- Analyst Decision
- NVGS Strong Buy
- YDES
- Analyst Count
- NVGS 2
- YDES 0
- Target Price
- NVGS $21.50
- YDES N/A
- AVG Volume (30 Days)
- NVGS 322.3K
- YDES 84.2K
- Earning Date
- NVGS 11-04-2025
- YDES 09-30-2025
- Dividend Yield
- NVGS 1.57%
- YDES N/A
- EPS Growth
- NVGS 33.99
- YDES N/A
- EPS
- NVGS 1.50
- YDES N/A
- Revenue
- NVGS $578,158,000.00
- YDES $510,360.00
- Revenue This Year
- NVGS $1.23
- YDES N/A
- Revenue Next Year
- NVGS $3.02
- YDES N/A
- P/E Ratio
- NVGS $12.00
- YDES N/A
- Revenue Growth
- NVGS 2.46
- YDES 45.76
- 52 Week Low
- NVGS $10.55
- YDES $5.30
- 52 Week High
- NVGS $17.99
- YDES $31.00
- Technical
- Relative Strength Index (RSI)
- NVGS 68.11
- YDES N/A
- Support Level
- NVGS $17.47
- YDES N/A
- Resistance Level
- NVGS $17.99
- YDES N/A
- Average True Range (ATR)
- NVGS 0.44
- YDES 0.00
- MACD
- NVGS 0.09
- YDES 0.00
- Stochastic Oscillator
- NVGS 90.37
- YDES 0.00
About NVGS Navigator Holdings Ltd. (Marshall Islands)
Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.